Sanome announces two UK hospital partnerships to deploy AI-powered clinical intelligence for earlier infection detection

LONDON, UK. Tuesday 16 December - Sanome, the health tech company behind MEMORI, an AI-powered clinical decision support tool that helps clinicians detect hospital-acquired infections (HAIs) earlier, has announced two major hospital partnerships to improve patient care. Earlier this year, MEMORI became the UK’s first multimodal Class IIb CE-marked AI Software as a Medical Device for infection prediction.

This comes at a critical time when health services prepare for soaring pressures during the winter months, when clinicians need to take swift and decisive action to prevent serious conditions like hospital-acquired infections from escalating.

The Royal Hospital for Neuro-disability and East Kent Hospitals University NHS Foundation Trust have each selected Sanome’s MEMORI platform to support earlier detection of hospital-acquired infections HAIs and clinical decision-making, which is especially important at this challenging time of year.

HAIs remain one of the most serious and costly challenges facing the NHS, contributing to over seven million additional patient bed days and £2.7 billion in annual care costs. Early detection is critical for preventing deterioration, easing clinical pressures, and improving patient outcomes.

MEMORI analyses real-time patient data using explainable clinical AI to identify emerging infection risk, with early studies showing the potential to surface life-threatening HAI predictions up to three days earlier than standard practice.

By flagging high-risk patients sooner and providing clear, actionable insights, the platform helps clinicians recognise deterioration earlier and deliver the right care at the right moment. Embedded directly within electronic patient records (EPRs), MEMORI brings these insights into clinicians’ existing workflows, enabling earlier, more confident decision-making.

The Royal Hospital for Neuro-disability, one of the UK’s leading specialist centres for long-term and complex neurological conditions, will become the first specialist neuro facility to embed MEMORI into routine patient care. Patients with complex neurological conditions are among the most vulnerable to infections and associated complications; in fact, more than six in ten of those admitted to intensive care units contract at least one HAI during their stay.

Through integration with the PatientSource EPR, MEMORI will support earlier detection across four wards initially, enabling clinicians to intervene sooner for a highly vulnerable patient population where timely action is essential.

In addition to the deployment of MEMORI in specialist neurological care, East Kent Hospitals University NHS Foundation Trust, one of England’s largest acute trusts, is also partnering with Sanome to integrate real-time AI insights directly into its EPR system to support early recognition of deteriorating patients. This collaboration lays the groundwork for a scalable new model for safe, secure access to real-time NHS data, supporting thousands of patients across multiple hospital sites.

“Partnering with leading healthcare organisations like the Royal Hospital for Neuro-disability and East Kent Hospitals University NHS Foundation Trust marks another major step towards bringing earlier, data-driven infection detection into everyday care for every patient,” said Benedikt von Thüngen, Founder and CEO of Sanome. “Working closely with clinicians, we’ve co-created a platform that not only flags those at risk but fits seamlessly into existing workflows. Our aim is to equip frontline teams with the actionable insights they need to intervene sooner and protect patients, at the same time relieving pressure on already-stretched resources.”

Bedside go-live dates at both sites in specialist neurological care are scheduled for the coming months, with additional NHS deployments planned throughout 2026 as Sanome continues to expand its footprint across UK healthcare.